Cited by 481Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityLiver physiology and pathology

The DOI matches its Crossref record.

Nonalcoholic Steatohepatitis

Elizabeth M. Brunt·2004·Seminars in Liver Disease

DOI 10.1055/s-2004-823098

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis. The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests. This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related cirrhosis.

Integrity signals

Registry

Crossref · 10.1055/s-2004-823098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 480

5-O-Demethylnobiletin Alleviates CCl4-Induced Acute Liver Injury by Equilibrating ROS-Mediated Apoptosis and Autophagy Induction
Chang, S. N., Kim, S. H., Dey, D. K., Park, S. M., Nasif, O., Bajpai, V. K., Kang, S. C., Lee, J., & Park, J. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031083 · Cited by 59
Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases
Assy, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i37.5834 · Cited by 60
Pattern of progression in liver injury following jejunoileal bypass for morbid obesity
Vyberg, M., Ravn, V., & Andersen, B. (1987) · Liver International · doi:10.1111/j.1600-0676.1987.tb00355.x · Cited by 57
Fatty liver, carotid disease and gallstones: A study of age-related associations
Lonardo, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5826 · Cited by 57
Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists
Polanco-Briceno, S., Glass, D., Stuntz, M., et al. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1946-1 · Cited by 57
Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease
Chang, J. P.-E., Goh, G. B., Leow, W. Q., Shen, L., Lim, K. H., & Tan, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199166 · Cited by 57
Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
Jo, M., Nishikawa, T., Nakajima, T., Okada, Y., Yamaguchi, K., Mitsuyoshi, H., Yasui, K., Minami, M., Iwai, M., Kagawa, K., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0392-z · Cited by 56
Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells
Yang, Y., Jiang, Y., Wang, Y.-T., & An, W. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.002 · Cited by 57
[Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects].
Lizardi-Cervera, J., Laparra, I. B., Chávez-Tapia, N. C., et al. (2007) · PubMed · Cited by 56
Schisandrin B: A Double‐Edged Sword in Nonalcoholic Fatty Liver Disease
Leong, P. K., & Ko, K. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6171658 · Cited by 56
Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein–1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease
Bai, Q., Zhang, X., Xu, L., Kakiyama, G., Heuman, D. M., Sanyal, A. J., Pandak, W. M., Yin, L., Xie, W., & Ren, S. (2012) · Metabolism · doi:10.1016/j.metabol.2011.11.014 · Cited by 55
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model
Fan, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.5053 · Cited by 55
Hepatic structural alteration in adult programmed offspring (severe maternal protein restriction) is aggravated by post-weaning high-fat diet
Souza‐Mello, V., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507771878 · Cited by 54
Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease
Gormaz, J. G., Rodrigo, R., Videla, L. A., & Beems, M. V. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.003 · Cited by 53
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity.
Shadid, S., & Jensen, M. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1053/s1542-3565(03)00198-8 · Cited by 52
Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
Cazzo, E., Pareja, J. C., & Chaim, É. A. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0306311216 · Cited by 54
Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients
Solga, S. F., Clark, J. M., Al-Khuraishi, A., et al. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2004.12.006 · Cited by 52
Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats
Radika, M. K., Viswanathan, P., & Anuradha, C. V. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.04.007 · Cited by 52
Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept
Bural, G. G., Torigian, D. A., Burke, A., Houseni, M., Alkhawaldeh, K. M., Cucchiara, A. J., Basu, S. K., & Alavi, A. A. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0258-4 · Cited by 51
Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Safwat, G. M., Pisanò, S., D’Amore, E., Borioni, G., Napolitano, M., Kamal, A. A., Ballanti, P., Botham, K. M., & Bravo, E. (2009) · Nutrition · doi:10.1016/j.nut.2009.02.009 · Cited by 51
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
Charrez, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2494 · Cited by 50
Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice
Park, M.-Y., Kim, S. J., Ko, E., Ahn, S., Seo, H., & Sung, M. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13158 · Cited by 52
Overweight and structural alterations of the liver in female rats fed a high-fat diet: a stereological and histological study.
Altunkaynak, B. Z., & Özbek, E. (2009) · The Turkish Journal of Gastroenterology · Cited by 51
Select Utilization of Obese Donors in Living Donor Liver Transplantation: Implications for the Donor Pool
Moss, J. R., Lapointe‐Rudow, D., Renz, J. F., Kinkhabwala, M. M., Dove, L. M., Gaglio, P. J., Emond, J. C., & Brown, R. S. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01124.x · Cited by 51
Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells
Kanuri, G., Spruss, A., Wagnerberger, S., Bischoff, S. C., & Bergheim, I. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.44 · Cited by 49
Nonalcoholic Fatty Liver in Children and Adolescents: An Overview
Corte, C. D., Alisi, A., Saccari, A., Vito, R. D., Vania, A., & Nobili, V. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.01.010 · Cited by 48
Diagnostic histochemistry in hepatic pathology
Iezzoni, J. C. (2018) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2018.10.003 · Cited by 52
Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study
Dvořák, K., Stritesky, J., Petrtýl, J., Vı́tek, L., Šroubková, R., Martin Lenicek, A., Smid, V., Haluzı́k, M., & Brůha, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111551 · Cited by 47
Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation
Cazzo, E., JÚNIOR, F. G., Pareja, J. C., & Chaim, É. A. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1183-4 · Cited by 46
Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
Tipoe, G. L., Ho, C.-T., Liong, E. C., et al. (2009) · PubMed · doi:10.14670/hh-24.1161 · Cited by 46
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
Jiang, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16464 · Cited by 49
Prediction of coronary atherosclerotic disease with liver transaminase level
Adibi, P., Sadeghi, M., Mahsa, M., Rozati, G., & Mohseni, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01545.x · Cited by 46
Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis
Zhao, L., Westerhoff, M., Pai, R. K., Choi, W.-T., Gao, Z.-H., & Hart, J. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.115 · Cited by 44
Allomyrina dichotoma (Arthropoda: Insecta) Larvae Confer Resistance to Obesity in Mice Fed a High-Fat Diet
Yoon, Y., Chung, M., Hwang, J., Han, M. W., Goo, T., & Yun, E. (2015) · Nutrients · doi:10.3390/nu7031978 · Cited by 47
A case–control study of non-alcoholic fatty liver disease in breast cancer
Bilici, A. E., Özgüroğlu, M., Mihmanlı, İ., et al. (2007) · Medical Oncology · doi:10.1007/s12032-007-0034-8 · Cited by 45
Adiponectin as a protective factor in hepatic steatosis
Méndez-Sánchez, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1737 · Cited by 45
Thyroid Function in Obese Children with Non-Alcoholic Fatty Liver Disease
Bilgin, H., & Pirgon, Ö. (2014) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1488 · Cited by 44
Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics
Lim, H.-W., & Bernstein, D. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.008 · Cited by 47
The α‐glucosidase inhibitor acarbose prevents obesity and simple steatosis in sequestosome 1/A170/p62 deficient mice
Okada, K., Yanagawa, T., Warabi, E., Yamastu, K., Uwayama, J., Takeda, K., Utsunomiya, H., Yoshida, H., Shoda, J., & Ishii, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00478.x · Cited by 44
Pediatric Nonalcoholic Fatty Liver Disease: A Comprehensive Review
Lindback, S., Gabbert, C. C., Johnson, B. L., Smorodinsky, E., Sirlin, C. B., Garcia, N. C., Pardee, P. E., Kistler, K. D., & Schwimmer, J. B. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.08.006 · Cited by 42
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease
Wei, J., Qiu, D., & Ma, X. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00369.x · Cited by 43
Acute and chronic hepatitis
Suriawinata, A. A., & Thung, S. N. (2006) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.11.001 · Cited by 44
Acarbose attenuates experimental non-alcoholic steatohepatitis
Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A. N., & DeCarli, L. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.116 · Cited by 44
Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis
Schneck, A., Anty, R., Patouraux, S., Bonnafous, S., Rousseau, D., Lebeaupin, C., Bailly-maitre, B., Sans, A., Tran, A., Gugenheim, J., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00344 · Cited by 37
Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress
Frühbeck, G., Gómez‐Ambrosi, J., Rodrı́guez, A., Ramírez, B., Valentí, V., Moncada, R., Becerril, S., Unamuno, X., Silva, C., Salvador, J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.04.004 · Cited by 42
Hepatic 11beta‐HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis
Kotsias-Konopelska, S., Kienitz, T., Hughes, B. A., Pirlich, M., Bauditz, J., Lochs, H. H., Strasburger, C. J., Stewart, P. M., & Quinkler, M. O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03358.x · Cited by 40
Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH)
Sazcı, A., Ergül, E., Aygün, C., et al. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1424 · Cited by 41
Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss
Catalán, V., Gómez‐Ambrosi, J., Rodrı́guez, A., Ramírez, B., Valentí, V., Moncada, R., Landecho, M. F., Silva, C., Salvador, J., & Frühbeck, G. (2016) · Diabetes · doi:10.2337/db16-0287 · Cited by 41
Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients
TINIAKOS, D. G. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.05.009 · Cited by 39
Hepatic and Extrahepatic Malignancies in Cirrhosis Caused by Nonalcoholic Steatohepatitis and Alcoholic Liver Disease
Kodama, K., Tokushige, K., Hashimoto, E., Taniai, M., & Shiratori, K. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01900.x · Cited by 40
CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 40
Nonalcoholic Fatty Liver Disease in Children
Mager, D. R., & Roberts, E. A. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.10.007 · Cited by 39
Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model
Tsujimoto, T., Kawaratani, H., Kitazawa, T., Hirai, T., Ohishi, H., Kitade, M., Yoshiji, H., Uemura, M., & Fukui, H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6036 · Cited by 39
Medical Treatment of Non-alcoholic Steatohepatitis
Kadayıfçı, A., Merriman, R. B., & Bass, N. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.001 · Cited by 38
Progressive Liver Disease in Patients With Ataxia Telangiectasia
Donath, H., Woelke, S., Theis, M., et al. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00458 · Cited by 38
Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice
Gao, X., Lin, X., Yan, X., Zhu, X., Li, X., Chen, M., Huang, Z., & Guo, H. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109347 · Cited by 38
Association Among C-Reactive Protein, Fatty Liver Disease, and Cardiovascular Risk
Lizardi-Cervera, J., Chávez-Tapia, N. C., Pérez-Bautista, O., Ramos, M. H., & Uribe, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9262-6 · Cited by 37
Brg1 promotes liver fibrosis via activation of hepatic stellate cells
Li, H., Lan, J., Han, C., Guo, K., Wang, G., Hu, J., Gong, J., Luo, X., & Cao, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.02.003 · Cited by 38
Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner
Berardi, D. E., Bock-Hughes, A., Terry, A. R., Drake, L. E., Bozek, G., & Macleod, K. F. (2022) · Science Advances · doi:10.1126/sciadv.abo2510 · Cited by 37
Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)
AGARWAL, N., & Sharma, B. C. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.012 · Cited by 37
No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV
Nakamura, M., Kanda, T., Nakamoto, S., Miyamura, T., Jiang, X., Wu, S., & Yokosuka, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081312 · Cited by 36
Mutation of Mitochondrial DNA in Livers From Patients With Alcoholic Hepatitis and Nonalcoholic Steatohepatitis
Kawahara, H., Fukura, M., Tsuchishima, M., & Takase, S. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00287.x · Cited by 36
Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease
Pirgon, Ö., Çekmez, F., Bilgin, H., et al. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.01.004 · Cited by 35
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus
Shigefuku, R., Takahashi, H., Nakano, H., Watanabe, T., Matsunaga, K., Matsumoto, N., Kato, M., Morita, R., Michikawa, Y., Tamura, T., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091545 · Cited by 34
Simultaneous proton density fat‐fraction and imaging with water‐specific T1 mapping (PROFIT1): application in liver
Thompson, R. B., Chow, K., Mager, D. R., Pagano, J. J., & Grenier, J. G. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28434 · Cited by 35
Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis
Takizawa, D., Kakizaki, S., Horiguchi, N., Yamazaki, Y., Tojima, H., & Mori, M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq277 · Cited by 35
Gold nanoparticles as cell regulators: beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity
Chen, H., Ng, J. P. M., Bishop, D., MILTHORPE, B. K., & Valenzuela, S. M. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0414-6 · Cited by 36
Biochemical Markers
Ahmed, M. H. (2007) · American Journal of Clinical Pathology · doi:10.1309/jxwum661t8vt1etx · Cited by 33
Sex difference in the liver of hepatocyte‐specific Pten‐deficient mice: A model of nonalcoholic steatohepatitis
Anezaki, Y., Ohshima, S., Ishii, H., Kinoshita, N., Dohmen, T., Kataoka, E., Sato, W., Iizuka, M., Goto, T., Sasaki, J., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00494.x · Cited by 32
Cardiovascular Disease and Nonalcoholic Fatty Liver Disease
Domanski, J. P., Park, S. J., & Harrison, S. A. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822fb3f7 · Cited by 33
Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?
Cano, A., Ciaffoni, F., Safwat, G. M., Aspichueta, P., Ochoa, B., Bravo, E., & Botham, K. M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00297.2009 · Cited by 33
MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis
Zhang, H., Yan, X., Guo, X.-X., Shi, M.-J., Lu, Y.-Y., Zhou, Q., Chen, Q., Hu, Y., Xu, L., Huang, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23262 · Cited by 32
Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
Pagadala, M. R., Zein, C. O., & McCullough, A. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.011 · Cited by 32
Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling
Thompson, K. J., Lau, K. N., Johnson, S., Martinie, J. B., Iannitti, D. A., McKillop, I. H., & Sindram, D. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00259.x · Cited by 32
Nonalcoholic Fatty Liver Disease: Prevalence, Influence on Age and Sex, and Relationship with Metabolic Syndrome and Insulin Resistance
Cheng, H.-Y., Wang, H., Chang, W.-H., Lin, S., Chu, C., Wang, T.-E., Liu, C., & Shih, S. (2013) · International journal of gerontology · doi:10.1016/j.ijge.2013.03.008 · Cited by 32
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review
Haghgoo, S. M., Sharafi, H., & Alavian, S. M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0357 · Cited by 31
The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study
Ali, A. H., Juboori, A. A., Petroski, G. F., Diaz‐Arias, A. A., Syed‐Abdul, M. M., Wheeler, A. A., Ganga, R., Pitt, J. B., Spencer, N., Hammoud, G. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051201 · Cited by 32
Non-alcoholic fatty liver disease (NAFLD) - A novel common aspect of the metabolic syndrome
Bogdanová, K., Poczatková, H., Uherková, L., Riegrová, D., Rypka, M., Fehér, J., Marchesini, G., & Veselý, J. (2006) · Biomedical Papers · doi:10.5507/bp.2006.014 · Cited by 31
Evolving trends in nonalcoholic fatty liver disease
Delgado, J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.02.034 · Cited by 31
Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
Losekann, A., Weston, A. C., Mattos, A. D., Tovo, C. V., Carli, L. D., Espindola, M., Pioner, S. R., & Coral, G. P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025552 · Cited by 30
Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72 protein phosphatase
Kim, S., Jeon, Y., Kim, H. S., Lee, J., Lim, H. J., Kang, D., Cho, H., Park, C. K., Lee, H., & Lee, C. (2015) · Hepatology · doi:10.1002/hep.28281 · Cited by 30
Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver
Yamagishi, S., Nakamura, K., Matsui, T., Sato, T., & Takeuchi, M. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.022 · Cited by 29
NONALCOHOLIC FATTY LIVER DISEASE IN SEVERE OBESE PATIENTS, SUBJECTED TO BARIATRIC SURGERY
Losekann, A., Weston, A. C., Carli, L. A. D., Espíndola, M. B., Pioner, S. R., & Coral, G. P. (2013) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032013000400009 · Cited by 30
Intake of Carbohydrate to Fiber Ratio Is a Useful Marker for Metabolic Syndrome in Patients with Type 2 Diabetes: A Cross-Sectional Study
Hashimoto, Y., Tanaka, M., Miki, A., Kobayashi, Y., Wada, S., Kuwahata, M., Kido, Y., Yamazaki, M., & Fukui, M. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000486550 · Cited by 30
Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice
Xiong, F., Zheng, Z., Xiao, L., Su, C., Chen, J., Gu, X., Tang, J., Zhao, Y., Luo, H., & Zha, L. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100067 · Cited by 29
Liver acoustic radiation force impulse (ARFI) in childhood obesity: comparison and correlation with biochemical markers
Kamble, R., Sodhi, K. S., Thapa, B. R., et al. (2016) · Journal of Ultrasound · doi:10.1007/s40477-016-0229-y · Cited by 29
Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
Oneta, C. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.10001 · Cited by 29
Standardized Salvia miltiorrhiza Extract Suppresses Hepatic Stellate Cell Activation and Attenuates Steatohepatitis Induced by a Methionine-Choline Deficient Diet in Mice
Lee, H. S., Son, W., Ryu, J.-E., Koo, B., & Kim, Y. S. (2014) · Molecules · doi:10.3390/molecules19068189 · Cited by 27
Protective Effect of Polyphenol-Rich Extract from Bee Pollen in a High-Fat Diet
Rzepecka‐Stojko, A., Kabała‐Dzik, A., Kubina, R., Jasik, K. P., Kajor, M., Wrześniok, D. M., & Stojko, J. (2018) · Molecules · doi:10.3390/molecules23040805 · Cited by 27
Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis
Chen, Y., Johansson, E., Yang, Y., Miller, M. L., Shen, D., Orlicky, D. J., Shertzer, H. G., Vasiliou, V., Nebert, D. W., & Dalton, T. P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.028 · Cited by 28
Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach: Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, Leptin-deficient Micenat Med 2000;6:998–1003
Hookman, P., & Barkin, J. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07670.x · Cited by 27
Pathogenesis of NASH and Promising Natural Products
Leng, Y., Zhang, M., Luo, J., & Zhang, H. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60002-x · Cited by 29
Pathological implications of cadherin zonation in mouse liver
Hempel, M., Schmitz, A., Winkler, S., Kücükoglu, Ö., Brückner, S., Niessen, C. M., & Christ, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1861-y · Cited by 27
Fatty liver disease
Brunt, E. M., Neuschwander‐Tetri, B. A., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00006-4 · Cited by 27
Self-citation
Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes
Woodford, R. M., Burton, P. R., O’Brien, P. E., Laurie, C., & Brown, W. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1623-9 · Cited by 26
The role of laminin–integrin signaling in triggering MB formation. An in vivo and in vitro study
Wu, Y., Li, N., Bardag‐Gorce, F., Li, J., French, B. A., Wilson, L. T., Dedes, J., & French, S. W. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.03.005 · Cited by 26
Metabolic Syndrome: Maladaptation to a Modern World
Wilkin, T. J., & Voss, L. D. (2004) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.97.11.511 · Cited by 46
Emerging drugs for non-alcoholic fatty liver disease
Federico, A., Niosi, M., Blanco, C. D. V., & Loguercio, C. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.145 · Cited by 25
Inflammatory mediators involved in the progression of the metabolic syndrome
Ma, K., Jin, X., Liang, X., Zhao, Q. D., & Zhang, X. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2291 · Cited by 24
Fatty Liver Disease
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35

Authors: Brunt, E. M.
Affiliations: Saint Louis University Hospital (US)
Corresponding author: Elizabeth M. Brunt
ORCID: Elizabeth M. Brunt
Venue: Seminars in Liver Disease
Publisher: Georg Thieme Verlag KG
Published: 2004-01
Volume: 24
Issue: 1
Pages: 3-20
ISSN: 0272-8087 (ISSN-L)
1098-8971
DOI: 10.1055/s-2004-823098
OpenAlex: W3149847267
Cited by: 481
References: 0
Citations by year: 2026: 2 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 14 · 2016: 24 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 31
FWCI: 29.48
Type: journal article
Language: en
Open access: closed
Locations: Seminars in Liver Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, metabolic syndrome, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, histopathology, pathophysiology, prevalence, insulin resistance, obesity
MeSH terms: Adolescent, Adult, Child, Fatty Liver, Fatty Liver, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Prevalence, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Steatohepatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks